Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.3B | 5.2B | 5.0B | 4.7B |
Cost of revenue | 3.1B | 3.0B | 3.0B | 3.1B |
Gross profit | 2.2B | 2.2B | 2.0B | 1.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.3B | 1.3B | 1.3B | 1.1B |
Operating income | 812.6M | 766.6M | 555.4M | 413.8M |
Non operating interest income | ||||
Income | 61.1M | 53.2M | 64.4M | 61.8M |
Expense | 9.0M | 5.8M | 8.1M | 6.9M |
Other income expense | — | — | — | — |
Pretax income | 971.6M | 855.2M | 725.4M | 168.2M |
Tax provision | 240.1M | 219.5M | 196.0M | 63.0M |
Net income | 731.5M | 635.7M | 529.4M | 105.2M |
Basic EPS | — | 23.3 | 19.4 | 3.9 |
Diluted EPS | — | 23.1 | 19.3 | 3.8 |
Basic average shares | — | 27.3M | 27.3M | 27.3M |
Diluted average shares | — | 27.5M | 27.5M | 27.5M |
EBITDA | 1.1B | 944.3M | 827.4M | 558.1M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |